(6aR,12bS)-3-Methyl-6-propyl-5,6,6a,7,8,12b-hexahydro-benzo[a]phenanthridine-10,11-diol

ID: ALA318338

PubChem CID: 10448883

Max Phase: Preclinical

Molecular Formula: C21H25NO2

Molecular Weight: 323.44

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCN1Cc2cc(C)ccc2[C@@H]2c3cc(O)c(O)cc3CC[C@H]21

Standard InChI:  InChI=1S/C21H25NO2/c1-3-8-22-12-15-9-13(2)4-6-16(15)21-17-11-20(24)19(23)10-14(17)5-7-18(21)22/h4,6,9-11,18,21,23-24H,3,5,7-8,12H2,1-2H3/t18-,21-/m1/s1

Standard InChI Key:  IFODQCSLFYJCSE-WIYYLYMNSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  1  0  0  0  0  0999 V2000
    1.7417   -3.3042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5042   -2.8625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0375   -2.8792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2667   -3.3125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5042   -1.9792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2792   -1.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7417   -4.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9792   -2.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0417   -1.9917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2167   -3.3125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9792   -4.6375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2167   -4.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2750   -4.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7542   -1.5292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2917   -0.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5042   -4.6375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7625   -0.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5292   -0.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7917   -3.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5458   -2.8667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5500   -4.6375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5417    0.6708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7875   -4.2125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5500   -4.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0292   -3.7542    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    1.7417   -2.4167    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  4  1  0
  4  2  1  0
  5  2  1  0
  6  5  2  0
  7  1  1  0
  8  1  2  0
  9  6  1  0
 10  8  1  0
 11  7  2  0
 12 10  2  0
 13 16  1  0
 14  5  1  0
 15  6  1  0
 16  7  1  0
 17 14  2  0
 18 17  1  0
 19  3  1  0
 20 10  1  0
 21 12  1  0
 22 18  1  0
 23 19  1  0
 24 23  1  0
  4 25  1  1
  2 26  1  6
 11 12  1  0
 13  4  1  0
  3  9  1  0
 15 18  2  0
M  END

Associated Targets(non-human)

Drd1 Dopamine D1 receptor (1900 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd2 Dopamine D2 receptor (7893 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adcy5 Adenylate cyclase type V (89 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd1 Dopamine receptors; D1 & D2 (258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 323.44Molecular Weight (Monoisotopic): 323.1885AlogP: 4.08#Rotatable Bonds: 2
Polar Surface Area: 43.70Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.56CX Basic pKa: 8.29CX LogP: 4.58CX LogD: 3.81
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.82Np Likeness Score: 0.61

References

1. Knoerzer TA, Watts VJ, Nichols DE, Mailman RB..  (1995)  Synthesis and biological evaluation of a series of substituted benzo[a]phenanthridines as agonists at D1 and D2 dopamine receptors.,  38  (16): [PMID:7636869] [10.1021/jm00016a009]

Source